A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases

Clinical trial NCT02633397 · COMPLETED

Trial details

NCT number: NCT02633397
Sponsor: Mark Gladwin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2017-04-11
Primary completion: 2022-05-04
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.